People: Prana Biotechnology Ltd (PRAN.O)

PRAN.O on Consolidated Issue listed on NASDAQ Capital Market

2.56USD
10 Jul 2014
Price Change (% chg)

$-0.05 (-1.92%)
Prev Close
$2.61
Open
$2.49
Day's High
$2.60
Day's Low
$2.43
Volume
1,682,671
Avg. Vol
1,306,179
52-wk High
$13.29
52-wk Low
$1.47

Search Stocks

Gozlan, Lawrence 

Brief Biography

Mr. Lawrence Gozlan has served as Non-Executive Independent Director of Prana Biotechnology Ltd since August 8, 2011. Mr. Gozlan, a biotechnology investor and advisor, is the Chief Investment Officer and Founder of Scientia Capital, a specialized global investment fund focused exclusively in life sciences. Scientia Capital was founded to provide high level experience and to manage investments for high net worth individuals, family offices and institutional investors seeking exposure to the biotechnology industry. Mr. Gozlan commenced his position with Scientia Capital in June 2006. Previously, Mr. Gozlan was responsible for the biotechnology investment portfolio in Australia as the institutional biotechnology analyst at the Queensland Investment Corporation (QIC), an investment fund with over AU$60 billion worth of assets under management. Mr. Gozlan also worked as the senior biotechnology analyst in the equities team at Foster Stock broking, and gained senior corporate finance experience advising life sciences companies at Deloitte. Mr. Gozlan is an investment advisor to several companies in the biotechnology industry, presented at numerous international healthcare conferences, and has been featured in various published media as an experienced person on investing in life sciences. He holds a Bachelor of Science with Honors in Microbiology and Immunology from the University of Melbourne, specializing in neurodegenerative diseases. He is Chairman of the Nomination Committee.

Basic Compensation

Total Annual Compensation, AUD Long-Term Incentive Plans, AUD All Other, AUD Fiscal Year Total, AUD
36,667 -- -- 36,667

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Geoffrey Kempler

738,647

Richard Revelins

151,271

Dianne Angus

344,045

Ira Shoulson

--

Lawrence Gozlan

36,667

Peter Marks

55,000
As Of 29 Jun 2013
Search Stocks